Pablo Vargas-Mora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pablo Vargas-Mora has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Valenzuela
Department of Dermatology, Faculty of Medicine, University of Chile, Santiago, Chile
6 shared publications Claudia Morales
Dermopathology Section, Pathology Service, Hospital Clínico Universidad de Chile, Santiago, Chile
5 shared publicationsDiego Orlandi
From the Department of Dermatology, Faculty of Medicine, Universidad de Chile, Santiago, Chile
5 shared publicationsLaura Carreño
Dermopathology Section, Pathology Service, Hospital Clínico Universidad de Chile , Santiago , Chile
5 shared publications- Daniel Morgado-Carrasco
Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Spain; Servicio de Dermatología, Hospital de Figueres, Fundació Salut Empordà, Spain
4 shared publications - Ruben Gonzalez-Cuevas
Faculty of Medicine, University of Chile, Santiago, Chile
4 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Elsevier in JAAD Case Reports
Dermatoscopy case of the month: Ultraviolet-induced fluorescence of yellow globules in adult xanthogranuloma
- 14 November 2026
- Published by Elsevier in JAAD Case Reports
Open AccessDermatoscopy case of the month: Ultraviolet-induced fluorescence of yellow globules in adult xanthogranuloma
- 4 September 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 390
Basosquamous carcinoma: closer to a basal cell carcinoma or a squamous cell carcinoma?
- 4 September 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 390
Basosquamous carcinoma: closer to a basal cell carcinoma or a squamous cell carcinoma?
- Open Access
- 23 March 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (2) , 501307
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Report of three cases
- 23 March 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (2) , 501307
Open AccessPrimary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Report of three cases
- 25 March 2025
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 52 (6) , 595-597
Reconstruction of a Complex Full-Thickness Auricular and Scalp Defect
- 25 March 2025
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 52 (6) , 595-597
Reconstruction of a Complex Full-Thickness Auricular and Scalp Defect
- 24 March 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (7)
Microsatellitosis of cutaneous melanomas in wide local excision specimens after excisional biopsy
- 24 March 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (7)
Microsatellitosis of cutaneous melanomas in wide local excision specimens after excisional biopsy
- 19 July 2024
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 51 (5) , 541-543
Reconstruction of 2 Simultaneous Defects Involving the Nasal Sidewall and Nasal Dorsum
- 19 July 2024
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 51 (5) , 541-543
Reconstruction of 2 Simultaneous Defects Involving the Nasal Sidewall and Nasal Dorsum
- 10 July 2024
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 51 (1) , 105-106
Use of Rubber Bands to Improve the Surgical Field in Patients With Multiple Trichilemmal Cysts
- 10 July 2024
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 51 (1) , 105-106
Use of Rubber Bands to Improve the Surgical Field in Patients With Multiple Trichilemmal Cysts
- 11 January 2024
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 28 (3) , 315
O’Brien’s Actinic Granuloma
- 11 January 2024
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 28 (3) , 315
O’Brien’s Actinic Granuloma
- Open Access
- 1 January 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (1) , 111-114
Dermatoscopia de carcinoma basocelular de pequeno diâmetro: estudo de caso‐controle
- 1 January 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (1) , 111-114
Open AccessDermatoscopia de carcinoma basocelular de pequeno diâmetro: estudo de caso‐controle
- 4 September 2023
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 64 (4) , e340-e347
Tumour budding in cutaneous squamous cell carcinoma: A novel prognosis risk factor
Introduction: Most cutaneous squamous cell carcinomas (cSCC) have a good prognosis, there is a small group where metastasis and death occur and the evaluation of this risk is still cause for controversy. Tumour budding is a pattern of histological invasion that is an emerging risk factor in other solid tumours.Objective: To examine the association between tumour budding and other known high‐risk predictors in cSCC. In addition, the impact of tumour budding on overall survival (OS) and disease‐specific survival (DSS) was analysed.Method: Retrospective study. It included patients with a diagnosis of non‐genital cSCC by excisional biopsy at a university hospital, between 2010 and 2020. A pathologist re‐analysed their histological slides and evaluated budding. Univariate and multivariate analyses were made to study the associations.Results: 156 cSCC biopsies were found, and positive tumour budding was found in 13.5%. This correlated with worse DSS and OS. On univariate analysis, budding was correlated with the diameter, thickness of the tumour, histological grade, level of invasion, perineural and lymphovascular invasion, previous radiotherapy, recurrent tumours and lymph node metastasis (LNM). Multivariate analysis: tumour budding was associated with poorly differentiated tumours, prior radiotherapy and LNM.Conclusion: An association was found between tumour budding and most known risk factors in cSCC. We found findings that indicate that the presence of tumour budding is associated with a worse prognosis in terms of LNM, OS and DSS. This supports the results of previous work which has suggested that budding could be related to high‐risk cSCC.
- 4 September 2023
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 64 (4) , e340-e347
Tumour budding in cutaneous squamous cell carcinoma: A novel prognosis risk factor
Introduction: Most cutaneous squamous cell carcinomas (cSCC) have a good prognosis, there is a small group where metastasis and death occur and the evaluation of this risk is still cause for controversy. Tumour budding is a pattern of histological invasion that is an emerging risk factor in other solid tumours.Objective: To examine the association between tumour budding and other known high‐risk predictors in cSCC. In addition, the impact of tumour budding on overall survival (OS) and disease‐specific survival (DSS) was analysed.Method: Retrospective study. It included patients with a diagnosis of non‐genital cSCC by excisional biopsy at a university hospital, between 2010 and 2020. A pathologist re‐analysed their histological slides and evaluated budding. Univariate and multivariate analyses were made to study the associations.Results: 156 cSCC biopsies were found, and positive tumour budding was found in 13.5%. This correlated with worse DSS and OS. On univariate analysis, budding was correlated with the diameter, thickness of the tumour, histological grade, level of invasion, perineural and lymphovascular invasion, previous radiotherapy, recurrent tumours and lymph node metastasis (LNM). Multivariate analysis: tumour budding was associated with poorly differentiated tumours, prior radiotherapy and LNM.Conclusion: An association was found between tumour budding and most known risk factors in cSCC. We found findings that indicate that the presence of tumour budding is associated with a worse prognosis in terms of LNM, OS and DSS. This supports the results of previous work which has suggested that budding could be related to high‐risk cSCC.